Publications
- Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Science
- Melodysplastic syndrome2016 | Faculty of Medicine in Hradec Králové
- Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II2013 | First Faculty of Medicine
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib2024 | First Faculty of Medicine
- Immune deregulation in myelodysplastic syndromes - the role of cytokines and soluble adhesion molecules. A pilot study2023 | Faculty of Medicine in Hradec Králové
- Treatment of polycythemia vera with ropeginterferon alfa‑2b in a young woman with a successful pregnancy – case report2023 | Faculty of Medicine in Hradec Králové
- Karotidynie (TIPIC syndrom) u pacientky s paroxysmální noční hemoglobinurií2022 | Faculty of Medicine in Hradec Králové
- MonoMAC syndrome with GATA2 novel mutation: A case report2022 | Faculty of Medicine in Hradec Králové
- Treatment strategies for myelodysplastic syndrome in 20212021 | Faculty of Medicine in Hradec Králové
Loading network view...